Search results for "Lymph nodes"

showing 10 items of 203 documents

Ultrasound detection of abdominal lymphadenomegaly in subjects with hepatitis C virus infection and persistently normal transaminases: a predictive i…

1998

The indications for liver biopsy in anti-HCV-positive patients with persistently normal alanine aminotransferase levels are not clearly established. Recent studies have correlated the presence of abdominal lymphoadenomegaly with disease severity in patients with chronic hepatitis C. Our study aimed to evaluate the frequency of abdominal lymphoadenomegaly in an anti-HCV positive blood donor population with persistently normal alanine aminotransferase and the relationship of abdominal lymphoadenomegaly with the severity of liver changes.Eighty-six anti-HCV positive blood donors (58 M, 28 F) with normal alanine aminotransferase were followed up for a median of 31 months (range 12-50). To evalu…

AdultMalemedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaLogistic ModelAdolescentPrognosiHepatitis C virusHepacivirusBiopsyPopulationBlood Donorsmedicine.disease_causeGastroenterologyRegression AnalysiInternal medicineAbdomenmedicineHumanseducationLymphatic Diseasesabdominal lymph nodes; chronic hepatitis c; normal transaminase; ultrasoundUltrasonographyeducation.field_of_studyHepatologymedicine.diagnostic_testbiologybusiness.industryUltrasoundAlanine TransaminaseHepatitis C AntibodiesHepatitis C ChronicMiddle Agedbiology.organism_classificationPrognosismedicine.anatomical_structureLogistic ModelsLiverLiver biopsyAbdomenRegression AnalysisFemaleViral diseaseLiver functionLymphatic DiseaseHepatitis C AntibodiebusinessHumanJournal of hepatology
researchProduct

Local staging of rectal carcinoma and assessment of the circumferential resection margin with high-resolution MRI using an integrated parallel acquis…

2005

Purpose To assess the diagnostic accuracy of integrated parallel acquisition technique (iPAT) in local staging of rectal carcinoma in comparison to conventional high-resolution MRI. Materials and Methods A total of 28 patients with a neoplasm of the rectum and 15 control patients underwent MRI of the pelvis. High-resolution images were acquired conventionally and with iPAT using a modified sensitivity encoding (mSENSE). Image quality, signal-to-noise and contrast-to-noise ratios (SNR, CNR), tumor extent, nodal status, and delineation of the circumferential resection margin (CRM) were compared. In 19 patients with a carcinoma, MR findings were correlated with the histopathological diagnosis.…

AdultMalemedicine.medical_specialtyRectumSensitivity and SpecificityMargin (machine learning)Rectal carcinomamedicineCarcinomaHumansRadiology Nuclear Medicine and imagingPelvisAgedNeoplasm StagingAged 80 and overRectal Neoplasmsbusiness.industryMiddle Agedmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureResection marginFemaleHistopathologyCircumferential resection marginLymph NodesRadiologybusinessJournal of Magnetic Resonance Imaging
researchProduct

Ultrasonography for the diagnosis of Lyme disease in cases of acute facial paralysis.

1992

Ultrasonography of the parotid gland was introduced in 1989 as part of the diagnostic protocol of every patient treated in our clinics with acute facial paralysis. Ten of 50 patients so tested were found to have unilateral nonpalpable enlarged lymph nodes in the caudal portion of the parotid gland around the stylomastoid foramen. All 10 patients were eventually diagnosed as having Lyme disease. It is suggested that in patients with acute facial paralysis, ultrasonography is an inexpensive tool to improve diagnosis of Lyme disease and may have a more useful purpose in monitoring therapy.

AdultMalemedicine.medical_specialtyStylomastoid foramenTime FactorsAdolescentFacial ParalysisDiagnosis DifferentialLyme diseasestomatognathic systemmedicineHumansParotid GlandIn patientChildUltrasonographyLyme DiseasePalsySalivary glandbusiness.industryMiddle Agedmedicine.diseaseFacial paralysisSurgeryParotid glandstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyAcute DiseaseFemaleLymph NodesUltrasonographybusinessThe Laryngoscope
researchProduct

Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort …

2016

Abstract Background and objectives The Axillary Lymph Node Dissection (ALND) is the standard treatment in patients with invasive breast cancer and sentinel node metastasis, but in 60% of the cases there is no further axillary neoplastic involvement, so this invasive intervention represents an overtreatment. The purpose of the study is to identify patients with low risk of additional nodal metastases, to omit ALND. Methods The MSKCC Additional nodal metastasis nomogram was applied on a sample of 175 patients with invasive breast cancer who underwent ALND after detection of macrometastasis with the extemporaneous examination of the sentinel lymph node. Patients were classified as "low risk" w…

AdultOncologyAxilla; Breast neoplasms; Lymph node excision; Lymphatic metastasis; Sentinel lymph node biopsy; Surgerymedicine.medical_specialtySentinel lymph nodeBreast Neoplasms030230 surgeryRisk AssessmentSensitivity and SpecificityCohort Studies03 medical and health sciences0302 clinical medicineBreast cancerSentinel lymph node biopsyPositive predicative valueInternal medicinemedicineHumansMacrometastasisLymph nodeAgedRetrospective StudiesLymphatic metastasiAged 80 and overBreast neoplasmbusiness.industryAxillary Lymph Node DissectionGeneral MedicineMiddle AgedModels TheoreticalNomogramSentinel nodemedicine.diseaseNomogramsLymph node excisionmedicine.anatomical_structureROC CurveArea Under CurveLymphatic Metastasis030220 oncology & carcinogenesisAxillaFemaleSurgeryLymph NodesSentinel Lymph NodebusinessInternational Journal of Surgery
researchProduct

p95HER-2 Predicts Worse Outcome in Patients with HER-2-Positive Breast Cancer

2006

AbstractBackground: The HER-2 receptor undergoes a proteolytic cleavage generating an NH2-terminally truncated fragment, p95HER-2, that is membrane-associated and tyrosine-phosphorylated. We have reported that p95HER-2, but not the full-length receptor, p185HER-2, correlated with the extent of lymph node involvement in patients with breast cancer and its expression was significantly enhanced in nodal metastatic tissue. These facts suggested an important role for p95HER-2 either as a marker or cause of metastasis and poor outcome in breast cancer. In this work, we have studied the prognostic value of p95HER-2 in breast cancer.Methods: Primary breast tumor tissues (n = 483) were from surgical…

AdultOncologyCancer ResearchPathologymedicine.medical_specialtyReceptor ErbB-2Breast NeoplasmsMetastasisBreast cancerRisk FactorsInternal medicineBiomarkers TumorTumor Cells CulturedmedicineCarcinomaHumansLymph nodeSurvival rateAgedAged 80 and overbusiness.industryCarcinoma Ductal BreastHazard ratioMiddle AgedPrognosismedicine.diseasePrimary tumorConfidence intervalSurvival RateCarcinoma Lobularmedicine.anatomical_structureReceptors EstrogenOncologyLymphatic MetastasisFemaleLymph NodesReceptors ProgesteronebusinessClinical Cancer Research
researchProduct

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positiv…

2015

Purpose Capecitabine is an active drug in metastatic breast cancer (BC). GEICAM/2003-10 is an adjuvant trial to investigate the integration of capecitabine into a regimen of epirubicin and docetaxel for node-positive early BC. Patients and Methods Patients with operable node-positive BC (T1-3/N1-3) were eligible. After surgery, 1,384 patients were randomly assigned to receive epirubicin plus cyclophosphamide (EC; 90 and 600 mg/m2, respectively, × four cycles), followed by docetaxel (100 mg/m2 × four cycles; EC-T) or epirubicin plus docetaxel (ET; 90 and 75 mg/m2, respectively, × four cycles), followed by capecitabine (1,250 mg/m2 twice a day on days 1 to 14, × four cycles; ET-X); all regime…

AdultOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentBreast NeoplasmsDocetaxelDisease-Free SurvivalDrug Administration ScheduleCapecitabineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsOdds RatiomedicineAdjuvant therapyHumansCyclophosphamideCapecitabineAgedEpirubicinNeoplasm StagingChemotherapybusiness.industryMiddle Agedmedicine.diseaseMetastatic breast cancerSurgeryRegimenTreatment OutcomeOncologyDocetaxelChemotherapy AdjuvantFluorouracilLymphatic MetastasisFemaleTaxoidsFluorouracilLymph NodesbusinessFollow-Up Studiesmedicine.drugEpirubicinJournal of Clinical Oncology
researchProduct

Is extracapsular nodal extension in sentinel nodes a predictor for nonsentinel metastasis and is there an impact on survival parameters?-A retrospect…

2016

The Z0011 trial has fundamentally changed axillary management in breast cancer patients. However, some important questions remain, like the role of extracapsular nodal extension (ENE) in positive sentinel nodes and the need for further axillary treatment. In this retrospective cohort study, we reviewed and analyzed data from 342 clinically node negative (cN0) breast cancer patients with a positive sentinel node and subsequent axillary lymph node dissection (ALND) from the BRENDA data base. The 104 (30.4%) ENE positive patients had a significantly higher proportion of ≥3 positive axillary lymph nodes (65.0%) compared to ENE negative patients with a positive sentinel node (21.4%). Likewise, E…

AdultOncologymedicine.medical_specialtyAxillary lymph nodesBreast NeoplasmsMetastasis03 medical and health sciences0302 clinical medicineBreast cancerPredictive Value of TestsInternal medicineInternal MedicinemedicineHumans030212 general & internal medicineLymph nodeAgedRetrospective StudiesAged 80 and overUnivariate analysisSentinel Lymph Node Biopsybusiness.industryAxillary Lymph Node DissectionRetrospective cohort studyMiddle AgedSentinel nodemedicine.diseaseSurvival Analysismedicine.anatomical_structureOncologyLymphatic Metastasis030220 oncology & carcinogenesisFemaleSurgerySentinel Lymph NodebusinessThe Breast Journal
researchProduct

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by E…

2011

Background: The Gruppo Oncologico Italia Meridionale 9902 trial compared four cycles of high-dose epirubicin plus cyclophosphamide (EC) with four cycles of docetaxel (Taxotere, D) followed by four cycles of EC as adjuvant treatment of node-positive breast cancer. Patients and methods: Patients were randomly assigned to EC (E 120 mg/m 2 , C 600 mg/m 2 , arm A) for four cycles or four cycles of D (100 mg/m 2 ) followed by four cycles of EC (arm B), both regimens every 21 days. Hormone receptor-positive patients were given hormonal therapy for 5 years. Primary end point was 5-year disease-free survival (DFS). Secondary objectives were overall survival (OS) and safety. Results: There were 750 p…

AdultOncologymedicine.medical_specialtyCyclophosphamideBreast NeoplasmsDocetaxelDisease-Free SurvivalBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyCyclophosphamideSurvival analysisEpirubicinGynecologyDose-Response Relationship Drugbusiness.industryCarcinomaHazard ratioOriginal ArticlesHematologyMiddle Agedmedicine.diseaseSurvival AnalysisItalyOncologyDocetaxelLymphatic MetastasisHormonal therapyFemaleTaxoidsLymph NodesbusinessAlgorithmsmedicine.drugEpirubicinAnnals of Oncology
researchProduct

Cytoskeletal Heterogeneity of an Epithelioid Sarcoma with Expression of Vimentin, Cytokeratins, and Neurofilaments

1990

We studied an unusual sarcoma with morphologic features diagnostic of epithelioid sarcoma by conventional light microscopy, transmission electron microscopy, and immunohistochemistry. The primary tumor, which was located in the deep soft tissues of the buttock of a 32-year-old woman, and its metastases to lymph nodes, liver, and lung were available for investigation. The histomorphological and ultrastructural appearance of the primary tumor and its metastatic deposits were typical of epithelioid sarcoma. Immunohistochemistry revealed a strong and uniform reactivity for vimentin in both the primary tumor and its metastases. In contrast, a marked cytoskeletal heterogeneity became evident for …

AdultPathologymedicine.medical_specialtyLung NeoplasmsNeurofilamentEpithelioid sarcomaIntermediate FilamentsVimentinBiologyEndoplasmic ReticulumPathology and Forensic MedicinemedicineHumansVimentinIntermediate filamentCytoskeletonLiver NeoplasmsSarcomamedicine.diseaseImmunohistochemistryPrimary tumorMicroscopy ElectronLymphatic Metastasisbiology.proteinButtocksKeratinsImmunohistochemistryFemaleSurgeryLymph NodesSarcomaLymphAnatomyThe American Journal of Surgical Pathology
researchProduct

Complications of Poly Implant Prothèse breast implants: the current discussion

2013

Against the background of the current discussion about Poly Implant Prothèse (PIP, Seyne-sur-mer, France) breast implants, we want to present a case demonstrating the complications such as implant rupture, silicone dissemination and level III silicone lymphadenopathy. A 29-year-old woman with cosmetic breast augmentation with PIP implants 5 years previously showed a sensitive swelling in her right axilla and neck region. All tests to detect an infectious or lymphomatous lymphadenopathy were negative. After ultrasound and MRI, rupture of the right implant was assumed and multiple pathologically enlarged lymph nodes up to supraclavicular region were shown. An excision biopsy of one axillary l…

AdultReoperationmedicine.medical_specialtyAxillary lymph nodesBiopsyBreast ImplantsBiomedical EngineeringProsthesis DesignSilicone Gelschemistry.chemical_compoundSiliconeBiopsymedicineHumansBreast ImplantationLymphatic DiseasesBreast augmentationLymph nodeDevice Removalmedicine.diagnostic_testbusiness.industryForeign-Body ReactionGeneral MedicineProsthesis FailureSurgeryAxillaTreatment Outcomemedicine.anatomical_structurechemistryAxillaLymph Node ExcisionFemaleSurgeryLymph NodesLymphImplantbusinessExpert Review of Medical Devices
researchProduct